The Beta-adrenergic receptor in pulmonary arterial hypertension: A novel therapeutic target?

Journal of the American College of Cardiology

Volumn 65, Issue 7, 2015, Pages 681-683

  Rubin, Lewis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

beta adrenergic receptor; nebivolol; pulmonary arterial hypertension

Indexed keywords

BETA ADRENERGIC RECEPTOR; ENDOTHELIN; IMATINIB; METOPROLOL; NEBIVOLOL; NITRIC OXIDE; PROSTACYCLIN; REACTIVE OXYGEN METABOLITE; BENZOPYRAN DERIVATIVE; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ETHANOLAMINE DERIVATIVE;

CELL PROLIFERATION; DRUG EFFECT; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; NONHUMAN; NOTE; PATHOGENESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; UNSPECIFIED SIDE EFFECT; ANIMAL; DRUG EFFECTS; HYPERTENSION, PULMONARY; MALE; VASCULAR ENDOTHELIUM; VASCULAR REMODELING;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANIMALS; BENZOPYRANS; ENDOTHELIUM, VASCULAR; ETHANOLAMINES; HUMANS; HYPERTENSION, PULMONARY; MALE; VASCULAR REMODELING;

EID: 84922778943     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.11.049     Document Type: Editorial

References (15)

1. N. Galiè, P.A. Corris, and A. Frost Updated treatment algorithm of pulmonary arterial hypertension J Am Coll Cardiol 62 Suppl 25 2013 D60 72
2. T. Pulido, I. Adzerikho, and R.N. Channick Macitentan and morbidity and mortality in pulmonary arterial hypertension N Engl J Med 369 2013 809 813
3. C.D. Burger, P.K. Long, and M.R. Shah Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL Registry Chest 146 2014 1263 1273
4. R.L. Benza, D.P. Miller, and R.J. Barst An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry Chest 142 2012 448 456
5. M. Humbert, O. Sitbon, and A. Chaouat Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
6. M. Humbert, D. Montani, and F. Perros Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension Vascul Pharmacol 49 2008 113 118
7. L.J. Rubin Metabolic dysfunction in the pathogenesis of pulmonary hypertension Cell Metab 12 2010 313 314
8. A. Vonk-Noordegraaf, F. Haddad, and K.M. Chin Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology J Am Coll Cardiol 62 Suppl 25 2013 D22 33
9. F. Perros, B. Ranchoux, and M. Izikki Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension J Am Coll Cardiol 65 2015 668 680
10. R.T. Schermuly, E. Dony, and H.A. Ghofrani Reversal of experimental pulmonary hypertension by PDGF inhibition J Clin Invest 115 2005 2811 2821
11. M.M. Hoeper, R.J. Barst, and R.C. Bourge Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study Circulation 127 2013 1128 1138
12. S. Andersen, J.G. Schultz, and A. Andersen Effects of bisoprolol and losartan treatment in the hypertrophic and failing right heart J Card Fail 11 2014 864 873
13. F.S. de Man, M.L. Handoko, and C. Guignabert Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? Am J Respir Crit Care Med 187 2013 14 19
14. A. Giaid, and D. Saleh Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension N Engl J Med 333 1995 214 221
15. S. Velez-Roa, A. Ciarka, and B. Najem Increased sympathetic nerve activity in pulmonary artery hypertension Circulation 110 2004 1308 1312